Doxazosin mesilate or mesylate

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C23H25N5O5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 86P6PQK0MU, chemically known as piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-, monomethanesulfonate, but more generally known as doxazosin mesylate, which bears US NIH Compound Identifier 3157. European Medicines Agency schedules doxazosin mesylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06384MIG. Most nations, for tariff purposes, schedule doxazosin mesylate under HS 29349990. As of Q4 2014, DOXAZOSIN MESYLATE remains US FDA's Preferred Term for this commodity. Doxazosin mesylate bears US NLM identifiers UMLS ID C0678136 and NCI Concept Code C29005. SMILES: COC1CC2C(CC1OC)NC(NC2N)N3CCN(CC3)C(=O)C4COC5CCCCC5O4.CS(=O)(=O)O.